Hospital Innovations Limited was founded in January 2008 by Chairman, Phil Davies, who has been directly involved within orthopaedics since 1983 and in that time has worked for some of the world’s leading orthopaedic device companies. It is Hospital Innovations' stated objective to deliver products and services to the medical community in a way that is both innovative and sustainable.
We are licensed and regulated by the Human Tissue Authority (HTA) and have successfully passed six HTA audits. All our US tissue bank partners are Food and Drug Administration (FDA) registered and accredited by the American Association of Tissue Banks (AATB). The products in our portfolio which are not allograft are all compliant with the Medical Device Regulations (MDR), regulated by The Medicines and Healthcare products Regulatory Agency (MHRA).
We offer multiple sterilisation options across our graft portfolio; including unique, industry changing techniques designed to ensure graft safety. To find out more, visit our Quality page.
Yes, we introduced the first allograft return service into the UK which is now a standard expectation across the industry. Providing all quality requirements are met, the allograft can be returned to our HTA licensed premises and stored free of charge until it is next required.
Yes, we have thousands of demonstration items that can be requested, with some items available to be loaned for use in theatre prior to purchase.
Details for our Business Development Managers can be found under our Meet the Team section.
Get in touch with our Customer Service team on 01443 719 555 to get up to date stock availability and pricing.
Yes, if there is an urgent requirement for an item we can dispatch with a same day courier. Please contact our Customer Service team on 01443 719 555 for further details.
Hospital Innovations Limited is a Sponsor of the National Ligament Registry